We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 141 funds opening new positions, 967 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 967 | Existing positions reduced: 887

4% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3882,365 (-23)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-23
Holders Change %
-0.96%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
141
Increased
967
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
PCA
826
Providence Capital Advisors
North Carolina
$5.16M -$19.2K -36 -0.4%
BFEC
827
Benjamin F. Edwards & Company
Missouri
$5.15M -$185K -348 -3%
OPW
828
Oxler Private Wealth
New York
$5.12M -$132K -248 -2%
RCM
829
Ratan Capital Management
Florida
$5.09M +$1.6M +3,000 +43%
SCM
830
Silvant Capital Management
Georgia
$5.07M -$1.79M -3,356 -25%
CHAM
831
Clear Harbor Asset Management
Connecticut
$5.04M +$636K +1,194 +14%
AMCA
832
Arthur M. Cohen & Associates
Illinois
$5.04M -$1.66B -3,114,080 -100%
PCA
833
Pallas Capital Advisors
Massachusetts
$5.04M +$1.36M +2,555 +28%
AF
834
Arrow Financial
New York
$5.03M -$725K -1,361 -12%
GGHC
835
Gilder Gagnon Howe & Co
New York
$5.03M +$78.3K +147 +2%
CI
836
Conning Inc
Connecticut
$5.02M -$173K -324 -3%
RWA
837
River Wealth Advisors
Pennsylvania
$5.02M +$137K +258 +3%
DADC
838
D.A. Davidson & Co
Montana
$5.01M -$337K -632 -6%
NPA
839
Nichols & Pratt Advisers
Massachusetts
$5.01M +$4.94M +9,267 +1,485%
SFI
840
Siemens Fonds Invest
Germany
$5M +$368K +691 +8%
LNWWM
841
Laird Norton Wetherby Wealth Management
California
$4.99M -$9.06K -17 -0.2%
GAAM
842
Guinness Atkinson Asset Management
California
$4.97M
MCCA
843
Mill Creek Capital Advisors
Pennsylvania
$4.93M -$60.7K -114 -1%
FFP
844
FourThought Financial Partners
Florida
$4.91M +$1.08M +2,023 +26%
IHL
845
Investment House LLC
California
$4.9M -$3.16M -5,928 -38%
SNB
846
Security National Bank
Nebraska
$4.89M -$158K -297 -3%
HEIP
847
Hudson Edge Investment Partners
New Jersey
$4.88M -$429K -806 -8%
CNBT
848
Canandaigua National Bank & Trust
New York
$4.85M -$109K -204 -2%
PJSIMP
849
P.J. Schmidt Investment Management (PJS)
Wisconsin
$4.82M +$26.1K +49 +0.5%
VI
850
Vestcor Inc
New Brunswick, Canada
$4.82M -$362K -680 -7%

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 135 closed out — a net gain of 6 holders — while 967 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,388 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +6 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.